The healthcare third-party logistics (3PL) market is experiencing significant growth due to increased production of pharmaceuticals and medical devices and the globalization of clinical trials. In addition, the increasing prevalence of chronic diseases has led to rising demand for the temperature-...Read More »
September 30, 2025
Aflibercept (Eylea) is a key anti-VEGF therapy used to treat wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. It is widely adopted due to its strong efficacy and convenient dosing schedule compared with other anti-VEGF agents. Market g...Read More »
September 30, 2025
Electrical Impedance Tomography (EIT) is a non-invasive, radiation-free medical imaging method that sends small electrical currents through surface electrodes, measures the resulting voltages, and creates images of tissue conductivity. Unlike traditional imaging techniques like CT or MRI, EIT prov...Read More »
September 30, 2025
The Risankizumab (Skyrizi) market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, ...Read More »
September 29, 2025
The escalating U.S. tariff regime and global trade tensions are reshaping the veterinary sector, exerting pressure on input costs, supply chain stability, service affordability, and long-term industry planning. The September 26, 2025, announcement imposing a 100% tariff on branded and patented pha...Read More »
September 29, 2025
Rivaroxaban, marketed as Xarelto, has been a leading treatment in the anticoagulant market, widely used for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. With its proven clinical efficacy, Xarelto has maintained a strong market presence globally. However, as...Read More »
September 29, 2025
Semaglutide, branded as Ozempic by Novo Nordisk, has become a key therapeutic for type 2 diabetes, with strong market performance due to its efficacy in blood sugar control. However, as the expiration of its patent approaches, the market for Ozempic is set to undergo significant changes. The impen...Read More »
September 26, 2025
The Biktarvy market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, emerging trend...Read More »
September 26, 2025
The global animal population is growing steadily, driven by rising pet ownership and expanding livestock demand. Companion animals, particularly dogs and cats, are increasingly integrated into households, with ownership surging across the U.S., UK, Australia, Mexico, and UAE, reflecting shifting d...Read More »
September 23, 2025
The global hernia surgery and devices market is experiencing rapid growth, fueled by increased hernia cases and heightened awareness of early diagnosis. The Cleveland Clinic estimates that approximately 20 million hernia surgeries are performed worldwide each year, including procedures like inguin...Read More »
September 22, 2025
The global pharmaceutical contract manufacturing market is witnessing notable shifts driven by intensifying geopolitical developments, trade policy interventions, and industry-led capacity expansions. These factors are reshaping outsourcing strategies across the value chain, further accelerating r...Read More »
September 22, 2025
The genetic testing market is undergoing rapid transformation, with spending up 66% between 2020 and 2024, reflecting rising utilization and high-cost testing. Adoption is shifting from ancestry-based curiosity to preventive and personalized healthcare, supported by insurers in Europe and Asia and...Read More »
September 18, 2025
The Daratumumab (DARZALEX) market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, ...Read More »
September 16, 2025
The field of genetically engineered microorganisms (GEMs) is undergoing a transformative evolution, driven by advances in synthetic biology, genome editing technologies, and systems-level automation. Once confined to niche industrial applications, GEMs are now at the forefront of innovation across...Read More »
September 15, 2025
The introduction of minimally invasive glaucoma surgery (MIGS) devices has resulted in the upliftment of glaucoma management industry. These new innovations provide a less invasive option compared to traditional procedures, which may lead to fewer complications and better patient outcomes. T...Read More »
September 12, 2025
The Tirzepatide (Mounjaro) market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, ...Read More »
September 11, 2025
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. To help understand and highlight the clinical trials development journey, we have made this study by profiling the state of R&D funding and initi...Read More »
September 2, 2025
The wound care market is witnessing sustained growth due to the rising global prevalence of chronic diseases and health conditions that impair the body’s natural wound-healing capabilities. Noncommunicable diseases (NCDs) such as diabetes, cardiovascular disorders, cancer, and obesity have b...Read More »
September 2, 2025
The diabetes clinical trials is experiencing robust growth driven by the increasing global burden of the disease, which is projected to affect over 853 million people by 2050. This dramatic rise is attributed to an aging global population, sedentary lifestyles, increasing rates of childhood and ad...Read More »
August 5, 2025
The U.S. independent freestanding emergency department market was valued at USD 1,458.71 million in 2024 and is expected to reach USD 1,985.64 million by 2030 at a CAGR of 5.28% from 2025 to 2030. The study covers independent freestanding emergency departments at state & county level which hel...Read More »
August 4, 2025